Formulary & Guidelines

Wirral Health Economy joined Pan Mersey APC in January 2018. We are currently in an interim period of merging the two formularies. Please be aware there will be pathways and guidelines on the Pan Mersey APC website that were approved prior to Wirral joining Pan Mersey APC.

The guidelines in the table below have been approved via the local decision making committees and where relevant NICE and other national guidance has been taken into account.

Applications for new medicines 

For Cheshire & Wirral Partnership NHS Foundation Trust guidelines and policies relating to mental health, please visit; http://www.cwp.nhs.uk/resources/policies/ and scroll down the page to policies. Under category please select ‘Medicines Management’ and press search to show the list of the current CWP medicines management policies.

Individual Funding Requests

Medicines within tariff are the responsibility of hospital trusts to fund. There are a number of drugs excluded from the tariff (PbR Excluded drugs) where primary care are charged separately.

For PbR excluded drugs outside NICE guidance and local guidelines, individual funding requests will be considered by the Individual Funding Request Team.

Guideline Comment
Medicine across wirral health economy  

Antibiotics

Antibiotic Guidelines (primary care) Pan Mersey  

 

 

Anticoagulation:

Anticoagulant (oral) - high INR pathway

Self-testing of INR – Patient/Practice Agreement (for adaptation by individual practice)

 

 

Adapted from the Wirral Oral Anticoagulation Guidelines for primary care

Atrial fibrillation:

Anticoagulation for Stroke Prevention in AF

Apixaban Checklist

Dabigatran Checklist

Rivaroxaban Checklist

Edoxaban Checklist

For other Patient Information Leaflets and Patient Alert Cards, please contact the individual manufacturers:

Apixaban – Pfizer: medical.information@bms.com or phone 0800 7311736
Dabigatran – Boehringer Ingelheim: Order online or
phone 01344 742579
Rivaroxaban - Bayer: Xmarketing@bayer.com or phone 01635 563116

Edoxaban – Daiichi-Sankyo: medinfo@daiichi-sankyo.co.uk or phone 08000285122

VTE/PE

Apixaban checklist (VTE and PE)

Dabigatran checklist (VTE and PE)

Edoxaban checklist (VTE and PE)

 

Rivaroxaban checklist (VTE and PE)

LMWH

Enoxaparin Guidelines

 

 

 

Anti-TNF agents - Planned conception in inflammatory arthritis  

C Difficile Information Sheet

 
Care of the Dying - non-renal  
Care of the Dying - severe renal failure  
Contraceptive guideline  

COPD

COPD guideline for inhaled therapy 
COPD Self Management Plan

 

Chronic constipation in adults in primary care guideline

 

Dexamethasone injection

 

Diabetes

Diabetes - Type 2 Diabetes Clinical Guideline

Diabetes - Blood Glucose Monitoring at Home (Adults)

 

Dosulepin

 

Dyspepsia and Gastro Oesophageal Reflux Disease

 

Eluxadoline

 
Erectile dysfunction  
Finasteride  

Flash Glucose Monitor (FreeStyle Libre)

Summary

Statement

Template primary care information

Template initiation information to primary care

Template continuation information to primary care

Template patient contract

 
Gastro-Oesophageal Reflux Disease in paediatrics  
Gout – British Society for Rheumatology (BSR) guideline  
Headache Pathway (adults) - Primary Care Guidance  
High strength insulin risk minimisation strategy  
Hypertension (primary uncomplicated) in adults  
Lipid lowering  
Liothyronine containing products guideline  
Mesalazine  
Neuropathic pain  
NSAIDs in Arthritis and Osteoarthritis in Adults  
Opioids and gabapentinoids  
Orphenadrine  
Osteoporosis Management Guidelines  
Palliative Care Symptoms guideline (NW Coast SCN)  
Parkinson's disease  
Sacubutril Valsartan (Entresto) Patient Information Leaflet  
Sequential use of biologics in psoriasis guideline  
Silk Garments  
Tapentadol immediate release preparations  
Thickeners for Dysphagia GP Fact Sheet  
Unlicensed and off-label medicines  
Vitamin D (adults)  

Please Note: Documents which are past their review date will only remain on the website if they are still clinically relevant. Some secondary care policies are also included here, where relevant to primary care and where there are links within in formulary chapters.